International Journal of Medical and Pharmaceutical Case Reports

Diabetes-related foot ulceration remains one of the most consequential complications of diabetes mellitus, and it accounts for a disproportionate share of hospital bed occupancy, lower-limb amputation and premature death among people living with the disease. Despite four decades of mechanistic research, several international guideline cycles and a considerable volume of randomised evidence, the proportion of people who achieve durable freedom from ulceration has changed far less than the volume of published work would suggest. This review examines why. It sets out to evaluate the strength and internal consistency of the evidence underpinning current understanding of ulcer causation, classification, treatment and prevention, and to identify where confident conclusions end and extrapolation begins. Literature was identified through structured searching of biomedical bibliographic sources and citation registries, supplemented by backward and forward citation tracking and by examination of contemporary international guidance, with critical appraisal focused on design adequacy, outcome definition, risk of bias, external validity and consistency across independent replications. Five themes emerged. First, the dominant causal model of neuropathy, deformity and trauma explains ulcer onset well but predicts recurrence poorly. Second, classification systems have proliferated without a corresponding improvement in comparability, and outcome definitions remain unstandardised across trials. Third, the evidence supporting core management is uneven, with mechanical offloading resting on more robust foundations than most adjunctive technologies. Fourth, prevention research has demonstrated efficacy under monitored conditions but has repeatedly failed to demonstrate effectiveness once adherence is treated as an outcome rather than a nuisance variable. Fifth, the geographical concentration of high-quality evidence in a small number of high-income settings limits generalisability to the populations bearing the greatest burden. Additionally, this paper records a case of a 39-year-old male. Finally it was concluded that the field would benefit less from additional small trials of novel dressings than from adequately powered pragmatic studies using standardised outcomes, with ulcer-free survival rather than time to closure as the primary measure of success.